4138.TWO · DMT
Taiwan · RS rating 50 · As of 2026-10-08
| Price | 53.80 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 50 / 52 / 76 / 27 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 16 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +18.3% |
| Sales growth Q/Q | +0.5% |
| Distance from 52-week high | +23.1% |
| Market cap (USD) | $66.9M |